REMD BIOTHERAPEUTICS, INC.

Organization

CAMARILLO, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Calcitonin gene-related peptide (CGRP) antagonist antibodies
- Patent number 11,629,184
- Issue date Apr 18, 2023
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating heart failure using glucagon receptor antagoni...
- Patent number 11,446,376
- Issue date Sep 20, 2022
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating type 1 diabetes using glucagon receptor antago...
- Patent number 11,447,555
- Issue date Sep 20, 2022
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunotherapy using antibodies that bind programmed death ligand-1...
- Patent number 11,332,531
- Issue date May 17, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of glucagon receptor antagonists and PI3K pathway inhib...
- Patent number 11,319,376
- Issue date May 3, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer treatment using antibodies that bind cytotoxic T-lymphocyte...
- Patent number 11,319,372
- Issue date May 3, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunotherapy using antibodies that bind Programmed Death 1 (PD-1)
- Patent number 11,248,049
- Issue date Feb 15, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-OX40 antibodies and methods of activating OX40
- Patent number 11,242,398
- Issue date Feb 8, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating heart failure using glucagon receptor antagoni...
- Patent number 10,765,737
- Issue date Sep 8, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating obesity and nonalcoholic fatty liver disease o...
- Patent number 10,752,693
- Issue date Aug 25, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating type 1 diabetes using glucagon receptor antago...
- Patent number 10,626,179
- Issue date Apr 21, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
NOVEL INTERFERON VARIANTS AND BIFUNCTIONAL FUSION MOLECULES THEREOF
- Publication number 20250145680
- Publication date May 8, 2025
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ENDOTHELIN RECEPTOR A (ETAR) ANTAGONIST ANTIBODIES
- Publication number 20230212300
- Publication date Jul 6, 2023
- REMD Biotherapeutics, Inc.
- Hai Yan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES
- Publication number 20230151104
- Publication date May 18, 2023
- REMD Biotherapeutics, Inc.
- Hai Yan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Recepto...
- Publication number 20220112294
- Publication date Apr 14, 2022
- REMD Biotherapeutics, Inc.
- Jim Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS USING ANTIBODIES...
- Publication number 20210079087
- Publication date Mar 18, 2021
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER TREATMENT USING ANTIBODIES THAT BIND HUMAN CD134 (OX40) RECE...
- Publication number 20210024640
- Publication date Jan 28, 2021
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CALCITONIN GENE-RELATED PEPTIDE (CGRP) ANTAGONIST ANTIBODIES
- Publication number 20200407433
- Publication date Dec 31, 2020
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONI...
- Publication number 20200353079
- Publication date Nov 12, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease O...
- Publication number 20200339697
- Publication date Oct 29, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antago...
- Publication number 20200239582
- Publication date Jul 30, 2020
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH LIGAND-1...
- Publication number 20200190197
- Publication date Jun 18, 2020
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER TREATMENT USING ANTIBODIES THAT BIND CYTOTOXIC T-LYMPHOCYTE...
- Publication number 20200055937
- Publication date Feb 20, 2020
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH 1 (PD-1)
- Publication number 20190330346
- Publication date Oct 31, 2019
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF GLUCAGON RECEPTOR ANTAGONISTS AND PI3K PATHWAY INHIB...
- Publication number 20190169300
- Publication date Jun 6, 2019
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Rare Genetic Disorders Using Glucagon Receptor...
- Publication number 20190062441
- Publication date Feb 28, 2019
- REMD Biotherapeutics, Inc.
- Hai Yan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Recepto...
- Publication number 20190002577
- Publication date Jan 3, 2019
- REMD Biotherapeutics, Inc.
- Jim Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONI...
- Publication number 20180256713
- Publication date Sep 13, 2018
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease O...
- Publication number 20180079820
- Publication date Mar 22, 2018
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antago...
- Publication number 20170240641
- Publication date Aug 24, 2017
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods For Treating Heart Failure Using Glucagon Receptor Antagonists
- Publication number 20170143673
- Publication date May 25, 2017
- REMD Biotherapeutics, Inc.
- Hai Yan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 6

Research Projects

Information Research Project
Assessment of Multiple Dose Administration ofGlucagon Receptor Bloc...
- Application id 10224813
- Award notice date Aug 3, 2021
Information Research Project
Assessment of Multiple Dose Administration ofGlucagon Receptor Bloc...
- Application id 10018859
- Award notice date Jul 28, 2020
Information Research Project
Assessment of Multiple Dose Administration of Glucagon Receptor Bl...
- Application id 9847842
- Award notice date Sep 16, 2019
Information Research Project
Assessment of the glucagon receptor blocker REMD-477 on insulin req...
- Application id 9517883
- Award notice date Aug 29, 2018
Information Research Project
Assessment of the glucagon receptor blocker REMD-477 on insulin req...
- Application id 9380671
- Award notice date Jun 28, 2017
Information Research Project
Assessment of the glucagon receptor blocker REMD-477 on insulin req...
- Application id 9041432
- Award notice date Aug 2, 2016

REMD BIOTHERAPEUTICS, INC.

Organization

Patents Grantslast 30 patents

Calcitonin gene-related peptide (CGRP) antagonist antibodies

Methods for treating heart failure using glucagon receptor antagoni...

Methods for treating type 1 diabetes using glucagon receptor antago...

Immunotherapy using antibodies that bind programmed death ligand-1...

Combination of glucagon receptor antagonists and PI3K pathway inhib...

Cancer treatment using antibodies that bind cytotoxic T-lymphocyte...

Immunotherapy using antibodies that bind Programmed Death 1 (PD-1)

Anti-OX40 antibodies and methods of activating OX40

Methods for treating heart failure using glucagon receptor antagoni...

Methods for treating obesity and nonalcoholic fatty liver disease o...

Methods for treating type 1 diabetes using glucagon receptor antago...

Patents Applicationslast 30 patents

NOVEL INTERFERON VARIANTS AND BIFUNCTIONAL FUSION MOLECULES THEREOF

HUMAN ENDOTHELIN RECEPTOR A (ETAR) ANTAGONIST ANTIBODIES

CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES

Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Recepto...

TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS USING ANTIBODIES...

CANCER TREATMENT USING ANTIBODIES THAT BIND HUMAN CD134 (OX40) RECE...

CALCITONIN GENE-RELATED PEPTIDE (CGRP) ANTAGONIST ANTIBODIES

METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONI...

Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease O...

Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antago...

IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH LIGAND-1...

CANCER TREATMENT USING ANTIBODIES THAT BIND CYTOTOXIC T-LYMPHOCYTE...

IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH 1 (PD-1)

COMBINATION OF GLUCAGON RECEPTOR ANTAGONISTS AND PI3K PATHWAY INHIB...

Methods For Treating Rare Genetic Disorders Using Glucagon Receptor...

Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Recepto...

METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONI...

Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease O...

Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antago...

Methods For Treating Heart Failure Using Glucagon Receptor Antagonists

NIH Research Projectlast 12 months

Research Projects

Assessment of Multiple Dose Administration ofGlucagon Receptor Bloc...

Assessment of Multiple Dose Administration ofGlucagon Receptor Bloc...

Assessment of Multiple Dose Administration of Glucagon Receptor Bl...

Assessment of the glucagon receptor blocker REMD-477 on insulin req...

Assessment of the glucagon receptor blocker REMD-477 on insulin req...

Assessment of the glucagon receptor blocker REMD-477 on insulin req...